Preliminary findings from Israel found people who received a fourth shot of Pfizer-BioNTech’s COVID-19 vaccine had a fivefold increase in antibodies a week later, The Wall Street Journal reported Jan. 4.
Read the full post on Becker's Hospital Review - Healthcare News
